<table id="SPLSERV-ebc1b349-e51b-c792-5d40-8f2bf65688bc" width="101%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 3: Incidence of Primary Endpoint Events</caption>
<col width="37%"></col>
<col width="11%"></col>
<col width="10%"></col>
<col width="17%"></col>
<col width="18%"></col>
<col width="8%"></col>
<tbody>
<tr>
<td align="left" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<br/>
</td>
<td align="center" colspan="2" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Incidence<br/>
</td>
<td align="center" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Risk Reduction<br/>
</td>
<td align="center" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">95 % C.l.<br/>
</td>
<td align="center" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">p-Value<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Losartan<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Placebo<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Primary Composite Endpoint<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">43.5%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">47.1%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">16.1%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">2.3% to 27.9%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">0.022<br/>
</td>
</tr>
<tr>
<td align="left" colspan="6" stylecode=" Lrule Rrule Botrule Toprule" valign="top">         Doubling of Serum Creatinine, ESRD and Death Occurring as a First Event<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">         Doubling of Serum Creatinine<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">21.6%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">26.0%<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">         ESRD<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">8.5%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">8.5%<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">         Death<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">13.4%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">12.6%<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<br/>
</td>
</tr>
<tr>
<td align="left" colspan="6" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Overall Incidence of Doubling of Serum Creatinine, ESRD and Death<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Doubling of Serum Creatinine<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">21.6%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">26.0%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">25.3%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">7.8% to 39.4%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">0.006<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">ESRD<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">19.6%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">25.5%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">28.6%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">11.5% to 42.4%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">0.002<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Death<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">21.0%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">20.3%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">-1.7%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">-26.9% to 18.6%<br/>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">0.884<br/>
</td>
</tr>
</tbody>
</table>